UPMC Outpatient Center
West Mifflin, Pennsylvania, 15236, United States
NCT Number: NCT06071884
The objective of the trial is to investigate the efficacy of the Bridge device in reducing post-operative pain and post-operative opioid consumption in patients undergoing rotator cuff surgery with the typical mode of anesthesia, nerve block plus propofol sedation.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
West Mifflin, Pennsylvania, 15236, United States
The interscalene block is the gold standard for postoperative pain management following rotator cuff surgery. However, the duration of the block does not cover rehabilitation. Therefore, in most cases, patients are discharged from the surgical center with an opioid prescription. There is a growing need to investigate complementary, non-pharmacologic pain-management methods. The Bridge device, which provides auricular neuromodulation of various cutaneous nerves near the ear, is manufactured by Masimo and previously FDA-approved to reduce symptoms of opioid withdrawal. It is a promising technology that could help relieve post-operative pain without exposing patients to the adverse effects of opioids or other pain-relieving medications. The objective of the trial is to investigate the efficacy of the Bridge device in reducing post-operative pain and post-operative opioid consumption in patients undergoing rotator cuff surgery with the typical mode of anesthesia, nerve block plus propofol sedation. Those enrolled will be assigned to a study group and compared to historic cohort (control group). Historic control group involves patients that underwent same surgical procedure performed at the surgical center involved in the study, by the same surgical operator, between 2020 and 2023.
*Prior to study enrollment, the outcome measure timepoints were updated to postoperative days (POD) 1, 3, 5, and 7. This was largely due to pain trajectories in surgical populations often follow a predictable, nonlinear course, with meaningful fluctuations most apparent on alternating days rather than daily increments. By assessing the outcome measures on POD 1, 3, 5, and 7, the revised scheduled timepoints continues to capture initial peak (POD 1), early recovery phase (POD3), the late recovery phase (POD 5), and the resolution/transition phase (POD 7) regarding pain trajectories.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The Bridge device is an FDA-cleared, drug-free, non-surgical device that uses neuro-modulation to aid in the reduction of symptoms associated with opioid withdrawal through application to branches of the Cranial Nerves V, VII, IX, X, and the occipital nerves. This study is investigating its effectiveness treating post-surgical pain.
Other names: NSS-2 BRIDGE
Time frame: Post-Operative Day 1
This outcome will be measured by total Oral Morphine Equivalents (OME, mg) abstracted from the medical records.
Time frame: Post-Operative Day 3
This outcome will be measured by total Oral Morphine Equivalents (OME, mg) abstracted from the medical records.
Time frame: Post-Operative Day 5
This outcome will be measured by total Oral Morphine Equivalents (OME, mg) abstracted from the medical records.
Time frame: Post-Operative Day 7
This outcome will be measured by total Oral Morphine Equivalents (OME, mg) abstracted from the medical records.
Time frame: Post-Operative Day 1
Pain scores will be completed on a Numeric Rating Scale (NRS) of 0=no pain at all and 10=the most severe pain.
Time frame: Post-Operative Day 3
Pain scores will be completed on a Numeric Rating Scale (NRS) of 0=no pain at all and 10=the most severe pain.
Time frame: Post-Operative Day 5
Pain scores will be completed on a Numeric Rating Scale (NRS) of 0=no pain at all and 10=the most severe pain.
Time frame: Post-Operative Day 5
Collected through the subject diary (response yes/no) and recorded as a count of participants
Time frame: Post-Operative Day 7
Collected through the subject diary (response yes/no) and recorded as a count of participants
Time frame: Post-Operative Day 5
Recorded as yes/no for adverse events related to opioids like nausea, vomiting, dizziness, and itching
Time frame: Post-Operative Day 7
Recorded as yes/no for adverse events related to opioids like nausea, vomiting, dizziness, and itching
Time frame: Post-operative Day 1
Recorded as yes/no for adverse events related to the device such as pain or skin irritation
Time frame: Post-operative Day 3
Recorded as yes/no for adverse events related to the device such as pain or skin irritation
Time frame: Post-operative Day 5
Recorded as yes/no for adverse events related to the device such as pain or skin irritation
Time frame: Post-operative Day 7
Recorded as yes/no for adverse events related to the device such as pain or skin irritation
Time frame: Post-Operative Day 7
Pain scores will be completed on a Numeric Rating Scale (NRS) of 0=no pain at all and 10=the most severe pain.
Steven Orebaugh
Other
Evaluation of Bridge Device in Pain Management for Outpatient Rotator Cuff Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07135375
Functionality, Neurologic Manifestations
Temuco, Chile
View Trial DetailsNCT02939209
Neurologic Manifestations, Pain
Halifax, Nova Scotia, Canada
View Trial DetailsNCT02007057
Neurologic Manifestations, Pain
Boulogne-Billancourt, France
View Trial DetailsNCT04094701
Femoracetabular Impingement, Femoral Acetabular Impingement
Chicago, Illinois, United States
View Trial Details